Journal Article DZNE-2026-00767

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Disruption of temporo-parietal network in Alzheimer's disease and its association with memory impairment.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
BioMed Central London

Alzheimer's research & therapy 18(1), 166 () [10.1186/s13195-026-02138-w]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Alzheimer's disease (AD) is characterised by the accumulation of β-amyloid (Aβ) and tau proteins, resulting in neurodegeneration and cognitive decline. Although Aβ and tau disrupt synaptic function, the association linking these molecular pathologies to network-level dysfunction and memory impairment remains poorly understood. Here, we investigated the effects of Aβ and tau pathology (CSF Aβ42/40 ratio and tau phosphorylated at position 181, p-tau-181, respectively) on effective connectivity related to memory encoding, which may provide a link between synaptic pathology and cognitive outcomes. Functional magnetic resonance imaging (fMRI) during visual memory encoding was acquired from 205 participants in the multicentric DZNE Longitudinal Cognitive Impairment and Dementia Study (DELCODE) across the AD spectrum. Effective connectivity was assessed using Dynamic Causal Modelling (DCM) of task-fMRI data, focusing on the parahippocampal place area (PPA), hippocampus (HC), and precuneus (PCU)-regions central to memory encoding. Disruptions in connectivity between temporal and parietal lobes were associated with both memory impairment and indices of AD pathology. Specifically, reduced positive effective connectivity from the PCU to the PPA and from the HC to the PCU were linked to higher p-tau-181 levels, with an amplification effect observed in the presence of amyloid accumulation for the latter connectivity. The disruption from the PCU to the PPA was found to be associated with decreased memory performance. Together, these findings indicate that temporo-parietal connectivity is associated with both AD molecular pathology and, for a subset of connections, with memory performance.

Keyword(s): Humans (MeSH) ; Alzheimer Disease: diagnostic imaging (MeSH) ; Alzheimer Disease: complications (MeSH) ; Alzheimer Disease: physiopathology (MeSH) ; Magnetic Resonance Imaging (MeSH) ; Parietal Lobe: diagnostic imaging (MeSH) ; Parietal Lobe: physiopathology (MeSH) ; Female (MeSH) ; Memory Disorders: diagnostic imaging (MeSH) ; Memory Disorders: etiology (MeSH) ; Memory Disorders: physiopathology (MeSH) ; Male (MeSH) ; tau Proteins: cerebrospinal fluid (MeSH) ; Amyloid beta-Peptides: cerebrospinal fluid (MeSH) ; Temporal Lobe: diagnostic imaging (MeSH) ; Temporal Lobe: physiopathology (MeSH) ; Aged (MeSH) ; Peptide Fragments: cerebrospinal fluid (MeSH) ; Neural Pathways: diagnostic imaging (MeSH) ; Neural Pathways: physiopathology (MeSH) ; Longitudinal Studies (MeSH) ; Neuropsychological Tests (MeSH) ; Aged, 80 and over (MeSH) ; Alzheimer's disease ; Beta-amyloid ; Memory impairment ; Neurodegeneration ; Synaptic aberration ; Tau ; tau Proteins ; Amyloid beta-Peptides ; Peptide Fragments ; amyloid beta-protein (1-42) ; amyloid beta-protein (1-40)

Classification:

Contributing Institute(s):
  1. Clinical Neurophysiology and Memory (AG Düzel)
  2. Epigenetics and Systems Medicine in Neurodegenerative Diseases (AG Fischer)
  3. Multimodal Neuroimaging (AG Maaß)
  4. Biomarker-Assisted Early Detection of Dementias (AG Peters)
  5. Interdisciplinary Dementia Research (AG Endres)
  6. Translational Dementia Research (Bonn) (AG Schneider)
  7. Patient Studies (Bonn) (Patient Studies (Bonn))
  8. Molecular biomarkers for predictive diagnostics of neurodegenerative diseases (AG Wiltfang)
  9. Clinical Dementia Research (Rostock /Greifswald) (AG Teipel)
  10. Parkinson Genetics (AG Gasser)
  11. Clinical Research Platform (CRP) (AG Spottke)
  12. Neuroinflammation, Biomarker (AG Heneka)
  13. Mathematics, statistics and informatics methods for support of population studies and clinical research (AG Schmid Bonn)
  14. Neuropsychology (AG Wagner)
  15. Clinical Alzheimer’s Disease Research (AG Jessen)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)
  2. 352 - Disease Mechanisms (POF4-352) (POF4-352)

Database coverage:
Medline ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > BN DZNE > BN DZNE-Patient Studies (Bonn)
Document types > Articles > Journal Article
Institute Collections > GÖ DZNE > GÖ DZNE-AG Wiltfang
Institute Collections > BN DZNE > BN DZNE-AG Schneider
Institute Collections > GÖ DZNE > GÖ DZNE-AG Fischer
Institute Collections > ROS DZNE > ROS DZNE-AG Teipel
Institute Collections > TÜ DZNE > TÜ DZNE-AG Gasser
Institute Collections > BN DZNE > BN DZNE-AG Spottke
Institute Collections > BN DZNE > BN DZNE-AG Jessen
Institute Collections > MD DZNE > MD DZNE-AG Düzel
Institute Collections > BN DZNE > BN DZNE-AG Wagner
Institute Collections > BN DZNE > BN DZNE-AG Heneka
Institute Collections > MD DZNE > MD DZNE-AG Maaß
Institute Collections > B DZNE > B DZNE-AG Peters
Institute Collections > B DZNE > B DZNE-AG Endres
Documents in Process
BN DZNE-AG Schmid Bonn
Public records
In process

 Record created 2026-07-20, last modified 2026-07-20


Restricted:
Download fulltext PDF Download fulltext PDF (PDFA)
External link:
Download fulltextFulltext by Pubmed Central
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)